Cargando…
Stromal Cell‐Derived Factor‐1 Mediates Cardiac Allograft Tolerance Induced by Human Endometrial Regenerative Cell‐Based Therapy
Endometrial regenerative cells (ERCs) are mesenchymal‐like stromal cells, and their therapeutic potential has been tested in the prevention of renal ischemic reperfusion injury, acute liver injury, ulcerative colitis, and immunosuppression. However, their potential in the induction of transplant tol...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6430050/ https://www.ncbi.nlm.nih.gov/pubmed/28941322 http://dx.doi.org/10.1002/sctm.17-0091 |
_version_ | 1783405718923116544 |
---|---|
author | Lan, Xu Wang, Grace Xu, Xiaoxi Lu, Shanzheng Li, Xiang Zhang, Baoren Shi, Ganggang Zhao, Yiming Du, Caigan Wang, Hao |
author_facet | Lan, Xu Wang, Grace Xu, Xiaoxi Lu, Shanzheng Li, Xiang Zhang, Baoren Shi, Ganggang Zhao, Yiming Du, Caigan Wang, Hao |
author_sort | Lan, Xu |
collection | PubMed |
description | Endometrial regenerative cells (ERCs) are mesenchymal‐like stromal cells, and their therapeutic potential has been tested in the prevention of renal ischemic reperfusion injury, acute liver injury, ulcerative colitis, and immunosuppression. However, their potential in the induction of transplant tolerance has not been investigated. The present study was undertaken to investigate the efficacy of ERCs in inducing cardiac allograft tolerance and the function of stromal cell‐derived factor‐1 (SDF‐1) in the ERC‐mediated immunoregulation. The inhibitory efficacy of human ERCs in the presence or absence of rapamycin was examined in both mouse cardiac allograft models between BALB/c (H‐2(d)) donors and C57BL/6 (H‐2(b)) recipients and in vitro cocultured splenocytes. AMD3100 was used to inhibit the function of SDF‐1. Intragraft antibody (IgG and IgM) deposition and immune cell (CD4(+) and CD8(+)) infiltration were measured by immunohistochemical staining, and splenocyte phenotypes were determined by fluorescence‐activated cell sorting analysis. The results showed that ERC‐based therapy induced donor‐specific allograft tolerance, and functionally inhibiting SDF‐1 resulted in severe allograft rejection. The negative effects of inhibiting SDF‐1 on allograft survival were correlated with increased levels of intragraft antibodies and infiltrating immune cells, and also with reduced levels of regulatory immune cells including MHC class II(low)CD86(low)CD40(low)dendritic cells, CD68(+)CD206(+)macrophages, CD4(+)CD25(+)Foxp3(+)T cells, and CD1d(high)CD5(high)CD83(low)IL‐10(high)B cells both in vivo and in vitro. These data showed that human ERC‐based therapy induces cardiac allograft tolerance in mice, which is associated with SDF‐1 activity, suggesting that SDF‐1 mediates the immunosuppression of ERC‐based therapy for the induction of transplant tolerance. Stem Cells Translational Medicine 2017;6:1997–2008 |
format | Online Article Text |
id | pubmed-6430050 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-64300502019-04-04 Stromal Cell‐Derived Factor‐1 Mediates Cardiac Allograft Tolerance Induced by Human Endometrial Regenerative Cell‐Based Therapy Lan, Xu Wang, Grace Xu, Xiaoxi Lu, Shanzheng Li, Xiang Zhang, Baoren Shi, Ganggang Zhao, Yiming Du, Caigan Wang, Hao Stem Cells Transl Med Translational Research Articles and Reviews Endometrial regenerative cells (ERCs) are mesenchymal‐like stromal cells, and their therapeutic potential has been tested in the prevention of renal ischemic reperfusion injury, acute liver injury, ulcerative colitis, and immunosuppression. However, their potential in the induction of transplant tolerance has not been investigated. The present study was undertaken to investigate the efficacy of ERCs in inducing cardiac allograft tolerance and the function of stromal cell‐derived factor‐1 (SDF‐1) in the ERC‐mediated immunoregulation. The inhibitory efficacy of human ERCs in the presence or absence of rapamycin was examined in both mouse cardiac allograft models between BALB/c (H‐2(d)) donors and C57BL/6 (H‐2(b)) recipients and in vitro cocultured splenocytes. AMD3100 was used to inhibit the function of SDF‐1. Intragraft antibody (IgG and IgM) deposition and immune cell (CD4(+) and CD8(+)) infiltration were measured by immunohistochemical staining, and splenocyte phenotypes were determined by fluorescence‐activated cell sorting analysis. The results showed that ERC‐based therapy induced donor‐specific allograft tolerance, and functionally inhibiting SDF‐1 resulted in severe allograft rejection. The negative effects of inhibiting SDF‐1 on allograft survival were correlated with increased levels of intragraft antibodies and infiltrating immune cells, and also with reduced levels of regulatory immune cells including MHC class II(low)CD86(low)CD40(low)dendritic cells, CD68(+)CD206(+)macrophages, CD4(+)CD25(+)Foxp3(+)T cells, and CD1d(high)CD5(high)CD83(low)IL‐10(high)B cells both in vivo and in vitro. These data showed that human ERC‐based therapy induces cardiac allograft tolerance in mice, which is associated with SDF‐1 activity, suggesting that SDF‐1 mediates the immunosuppression of ERC‐based therapy for the induction of transplant tolerance. Stem Cells Translational Medicine 2017;6:1997–2008 John Wiley and Sons Inc. 2017-09-23 /pmc/articles/PMC6430050/ /pubmed/28941322 http://dx.doi.org/10.1002/sctm.17-0091 Text en © 2017 The Authors stem cells translational medicine published by Wiley Periodicals, Inc. on behalf of AlphaMed Press This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
spellingShingle | Translational Research Articles and Reviews Lan, Xu Wang, Grace Xu, Xiaoxi Lu, Shanzheng Li, Xiang Zhang, Baoren Shi, Ganggang Zhao, Yiming Du, Caigan Wang, Hao Stromal Cell‐Derived Factor‐1 Mediates Cardiac Allograft Tolerance Induced by Human Endometrial Regenerative Cell‐Based Therapy |
title | Stromal Cell‐Derived Factor‐1 Mediates Cardiac Allograft Tolerance Induced by Human Endometrial Regenerative Cell‐Based Therapy |
title_full | Stromal Cell‐Derived Factor‐1 Mediates Cardiac Allograft Tolerance Induced by Human Endometrial Regenerative Cell‐Based Therapy |
title_fullStr | Stromal Cell‐Derived Factor‐1 Mediates Cardiac Allograft Tolerance Induced by Human Endometrial Regenerative Cell‐Based Therapy |
title_full_unstemmed | Stromal Cell‐Derived Factor‐1 Mediates Cardiac Allograft Tolerance Induced by Human Endometrial Regenerative Cell‐Based Therapy |
title_short | Stromal Cell‐Derived Factor‐1 Mediates Cardiac Allograft Tolerance Induced by Human Endometrial Regenerative Cell‐Based Therapy |
title_sort | stromal cell‐derived factor‐1 mediates cardiac allograft tolerance induced by human endometrial regenerative cell‐based therapy |
topic | Translational Research Articles and Reviews |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6430050/ https://www.ncbi.nlm.nih.gov/pubmed/28941322 http://dx.doi.org/10.1002/sctm.17-0091 |
work_keys_str_mv | AT lanxu stromalcellderivedfactor1mediatescardiacallografttoleranceinducedbyhumanendometrialregenerativecellbasedtherapy AT wanggrace stromalcellderivedfactor1mediatescardiacallografttoleranceinducedbyhumanendometrialregenerativecellbasedtherapy AT xuxiaoxi stromalcellderivedfactor1mediatescardiacallografttoleranceinducedbyhumanendometrialregenerativecellbasedtherapy AT lushanzheng stromalcellderivedfactor1mediatescardiacallografttoleranceinducedbyhumanendometrialregenerativecellbasedtherapy AT lixiang stromalcellderivedfactor1mediatescardiacallografttoleranceinducedbyhumanendometrialregenerativecellbasedtherapy AT zhangbaoren stromalcellderivedfactor1mediatescardiacallografttoleranceinducedbyhumanendometrialregenerativecellbasedtherapy AT shiganggang stromalcellderivedfactor1mediatescardiacallografttoleranceinducedbyhumanendometrialregenerativecellbasedtherapy AT zhaoyiming stromalcellderivedfactor1mediatescardiacallografttoleranceinducedbyhumanendometrialregenerativecellbasedtherapy AT ducaigan stromalcellderivedfactor1mediatescardiacallografttoleranceinducedbyhumanendometrialregenerativecellbasedtherapy AT wanghao stromalcellderivedfactor1mediatescardiacallografttoleranceinducedbyhumanendometrialregenerativecellbasedtherapy |